| Standardisation of spirometry MR Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, ... European respiratory journal 26 (2), 319-338, 2005 | 18290* | 2005 |
| Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study NR Anthonisen, JE Connett, JP Kiley, MD Altose, WC Bailey, AS Buist, ... Jama 272 (19), 1497-1505, 1994 | 2449 | 1994 |
| A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema National Emphysema Treatment Trial Research Group New England Journal of Medicine 348 (21), 2059-2073, 2003 | 2128 | 2003 |
| The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial NR Anthonisen, MA Skeans, RA Wise, J Manfreda, RE Kanner, ... Annals of internal medicine 142 (4), 233-239, 2005 | 1430 | 2005 |
| Cyclophosphamide versus placebo in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, J Goldin, MD Roth, DE Furst, ... New England Journal of Medicine 354 (25), 2655-2666, 2006 | 1259 | 2006 |
| Long-term effects of budesonide or nedocromil in children with asthma Childhood Asthma Management Program Research Group New England Journal of Medicine 343 (15), 1054-1063, 2000 | 1243 | 2000 |
| Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease Lung Health Study Research Group New England Journal of Medicine 343 (26), 1902-1909, 2000 | 981 | 2000 |
| Patients at high risk of death after lung-volume–reduction surgery National Emphysema Treatment Trial Research Group New England Journal of Medicine 345 (15), 1075-1083, 2001 | 619 | 2001 |
| Effect of weight loss on upper airway collapsibility in obstructive sleep apnea1-3 AR Schwartz, AR Gold, N Schubert, A Stryzak Am Rev Respir Dis 144 (3 pt 1), 494-498, 1991 | 513 | 1991 |
| Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee LP McGarvey, M John, JA Anderson, M Zvarich, RA Wise Thorax 62 (5), 411-415, 2007 | 497 | 2007 |
| C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease SFP Man, JE Connett, NR Anthonisen, RA Wise, DP Tashkin, DD Sin Thorax 61 (10), 849-853, 2006 | 455 | 2006 |
| Predictors of mortality in patients with emphysema and severe airflow obstruction FJ Martinez, G Foster, JL Curtis, G Criner, G Weinmann, A Fishman, ... American journal of respiratory and critical care medicine 173 (12), 1326-1334, 2006 | 454 | 2006 |
| Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis B White, WC Moore, FM Wigley, HQ Xiao, RA Wise Annals of internal medicine 132 (12), 947-954, 2000 | 450 | 2000 |
| Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea IC Gleadhill, AR Schwartz, N Schubert, RA Wise, S Permutt, PL Smith American Review of Respiratory Disease 143 (6), 1300-1303, 1991 | 439 | 1991 |
| Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, MD Roth, DE Furst, RM Silver, ... American journal of respiratory and critical care medicine 176 (10), 1026-1034, 2007 | 425 | 2007 |
| Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test RA Wise, CD Brown COPD: Journal of Chronic Obstructive Pulmonary Disease 2 (1), 125-129, 2005 | 423 | 2005 |
| Upper airway pressure-flow relationships in obstructive sleep apnea PL Smith, RA Wise, AR Gold, AR Schwartz, S Permutt Journal of Applied Physiology 64 (2), 789-795, 1988 | 421 | 1988 |
| Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study FM Wigley, RA Wise, JR Seibold, DA McCloskey, G Kujala, TA Medsger, ... Annals of Internal Medicine 120 (3), 199-206, 1994 | 420 | 1994 |
| Measuring adherence to asthma medication regimens CS Rand, RA Wise American Journal of Respiratory and Critical Care Medicine 149 (2), 69-76, 1994 | 386 | 1994 |
| Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length F Sciurba, GJ Criner, SM Lee, Z Mohsenifar, D Shade, W Slivka, RA Wise American journal of respiratory and critical care medicine 167 (11), 1522-1527, 2003 | 375 | 2003 |
Fernando Martinezprofessor of medicine, weill cornellVerified email at med.cornell.edu
